Skip to main content
# Title Research Year
121 Palliative Hypofractionated Radiotherapy in South Egyptian Patients with Stage III and IV Non -Small Cell Lung Cancer 2015
122 Reply 2015
123 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
124 Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?
2015
125 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer 2015
126 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
127 Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?
2015
128 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer 2015
129 Clinical Outcomes of Estrogen Negative- Progesterone Positive Invasive Breast Cancer, Retrospective Study 2015
130 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015